The European Cystic Fibrosis Society is pleased to announce that the official 2023 Impact Factors (IF) were recently released, and the Journal of Cystic Fibrosis (JCF) has increased its IF from the 2022 IF of 5.2 to 5.4. JCF ranks 15th in the Respiratory System category.

The Journal Impact Factor is published each year by Clarivate Analytics.
It is a measure of the number of times an average paper in a particular journal is cited during the preceding two years.

This achievement underscores the hard work and dedication of the editorial team, reviewers, and authors. It reflects the high standards and impactful research that the Journal of Cystic Fibrosis consistently delivers.

The ECFS would like to thank the Editor in Chief, Dr. Patrick Flume, and the Editorial Board. Their excellent work has helped JCF gain its current standings and continues to aid its growth.

IF_JCF_500.jpg [1]